Gene ontology annotations for HIST1H2AB |
|
Experiment description of studies that identified HIST1H2AB in exosomes |
1 |
Experiment ID |
76 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|GAPDH|HSP90|CD81|CD9|CD63|LAMP1|MHCI
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20224111
|
Organism |
Homo sapiens |
Experiment description |
Proteomics analysis of bladder cancer exosomes. |
Authors |
"Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A." |
Journal name |
MCP
|
Publication year |
2010 |
Sample |
Bladder cancer cells |
Sample name |
HT1376 |
Isolation/purification methods |
Differential centrifugation Sucrose density gradient |
Flotation density |
1.10-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [MALDI TOF/TOF] Western blotting FACS |
|
|
2 |
Experiment ID |
21 |
MISEV standards |
✔
EM|IEM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD63
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
19837982
|
Organism |
Homo sapiens |
Experiment description |
Proteomic and bioinformatic analysis of immunoaffinity-purified exosomes derived from the human colon tumor cell line LIM1215. |
Authors |
"Suresh Mathivanan, Justin W.E. Lim, Bow J. Tauro, Hong Ji, Robert L. Moritz and Richard J. Simpson" |
Journal name |
MCP
|
Publication year |
2009 |
Sample |
Colorectal cancer cells |
Sample name |
LIM1215 |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.10-1.12 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [Orbitrap] Western blotting |
|
|
3 |
Experiment ID |
207 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
4 |
Experiment ID |
208 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
5 |
Experiment ID |
209 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
6 |
Experiment ID |
235 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
HKCI-8 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
7 |
Experiment ID |
236 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocellular carcinoma cells |
Sample name |
MHCC97L |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RT-PCR RNA Sequencing |
|
|
8 |
Experiment ID |
237 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|HSC70|GAPDH
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✔
qNano
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
26054723
|
Organism |
Homo sapiens |
Experiment description |
Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs |
Authors |
"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N" |
Journal name |
Carcinogenesis
|
Publication year |
2015 |
Sample |
Hepatocytes |
Sample name |
MIHA |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.19 g/mL
|
Molecules identified in the study |
Protein RNA |
Methods used in the study |
Western blotting Mass spectrometry RNA Sequencing |
|
|
9 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
10 |
Experiment ID |
211 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
cytochrome c|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
IGROV1 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
11 |
Experiment ID |
212 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
Cytochrome C|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
OVCAR-3 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
12 |
Experiment ID |
138 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
13 |
Experiment ID |
140 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
VCaP - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
14 |
Experiment ID |
141 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
VCaP - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
15 |
Experiment ID |
142 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|LAMP2|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
LNCaP - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
16 |
Experiment ID |
144 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
17 |
Experiment ID |
145 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|RAB5|CD10
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
C4-2 - Rep 3 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
18 |
Experiment ID |
146 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
HSP70|HSP90|CD9
|
Enriched markers |
✔
HSP90B1
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
|
PubMed ID |
22723089
|
Organism |
Homo sapiens |
Experiment description |
Prostate cancer cell derived exosomes |
Authors |
"Hosseini-Beheshti E, Guns ES." |
Journal name |
MCP
|
Publication year |
2012 |
Sample |
Prostate cancer cells |
Sample name |
RWPE - Rep 2 |
Isolation/purification methods |
Sucrose density gradient |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [QTOF] |
|
|
19 |
Experiment ID |
834 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
LAMP2|CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
20 |
Experiment ID |
835 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
21 |
Experiment ID |
66 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✔
TSG101|Alix|CD63|CD81
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19199708
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). |
Authors |
"Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, Yates JR" |
Journal name |
JPR
|
Publication year |
2009 |
Sample |
Saliva |
Sample name |
Saliva |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
22 |
Experiment ID |
191 |
MISEV standards |
✘
|
Biophysical techniques |
✔
Alix|CD81|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
20124223
|
Organism |
Homo sapiens |
Experiment description |
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. |
Authors |
"Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2010 |
Sample |
Squamous carcinoma cells |
Sample name |
Squamous carcinoma cell (A431) |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
23 |
Experiment ID |
217 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|CD81|CD9|CD63
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23844026
|
Organism |
Homo sapiens |
Experiment description |
Characterization of human thymic exosomes. |
Authors |
"Skogberg G, Gudmundsdottir J, van der Post S, Sandstrom K, Bruhn S, Benson M, Mincheva-Nilsson L, Baranov V, Telemo E, Ekwall O." |
Journal name |
PLoS One
|
Publication year |
2013 |
Sample |
Thymus |
Sample name |
Normal-Thymus |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for HIST1H2AB |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
HIST1H2BC |
8347 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
2 |
HIST2H2BE |
8349 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
3 |
ACTR2 |
10097 |
Co-fractionation |
 |
Homo sapiens |
|
4 |
SENP3 |
26168 |
Affinity Capture-MS |
 |
Homo sapiens |
|
5 |
RPL26L1 |
51121 |
Affinity Capture-MS |
 |
Homo sapiens |
|
6 |
HIST2H2AB |
317772 |
Affinity Capture-MS |
 |
Homo sapiens |
|
7 |
ARID5B |
84159 |
Affinity Capture-MS |
 |
Homo sapiens |
|
8 |
HIST1H4A |
8359 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
9 |
XPC |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
10 |
HIST1H1D |
3007 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
11 |
BRCA1 |
672 |
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
Co-crystal Structure |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
|
12 |
HLTF |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
13 |
KIF20A |
10112 |
Affinity Capture-MS |
 |
Homo sapiens |
|
14 |
HIST1H2BB |
3018 |
Reconstituted Complex |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
15 |
MRPL27 |
51264 |
Affinity Capture-MS |
 |
Homo sapiens |
|
16 |
UBC |
7316 |
Affinity Capture-Western |
 |
Homo sapiens |
|
17 |
HIST3H2BB |
128312 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
18 |
DHX57 |
90957 |
Affinity Capture-MS |
 |
Homo sapiens |
|
19 |
KMT2C |
58508 |
Reconstituted Complex |
 |
Homo sapiens |
|
20 |
PARK7 |
11315 |
Affinity Capture-MS |
 |
Homo sapiens |
|
21 |
LARP7 |
51574 |
Affinity Capture-MS |
 |
Homo sapiens |
|
22 |
CENPA |
|
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
|
23 |
XRCC1 |
7515 |
Affinity Capture-MS |
 |
Homo sapiens |
|
24 |
HIST1H2BD |
3017 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
25 |
SART3 |
9733 |
Affinity Capture-MS |
 |
Homo sapiens |
|
26 |
HIST1H2BM |
8342 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
27 |
MCM2 |
4171 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
28 |
USP3 |
9960 |
Affinity Capture-Western |
 |
Homo sapiens |
|
29 |
COPS5 |
10987 |
Affinity Capture-MS |
 |
Homo sapiens |
|
30 |
PRC1 |
9055 |
Affinity Capture-MS |
 |
Homo sapiens |
|
31 |
KMT2D |
8085 |
Reconstituted Complex |
 |
Homo sapiens |
|
32 |
SUPT5H |
6829 |
Affinity Capture-MS |
 |
Homo sapiens |
|
33 |
MICAL1 |
64780 |
Affinity Capture-MS |
 |
Homo sapiens |
|
34 |
MCM6 |
4175 |
Affinity Capture-MS |
 |
Homo sapiens |
|
35 |
HIST2H2AC |
8338 |
Affinity Capture-MS |
 |
Homo sapiens |
|
36 |
ITGA4 |
3676 |
Affinity Capture-MS |
 |
Homo sapiens |
|
37 |
ATRX |
546 |
Affinity Capture-MS |
 |
Homo sapiens |
|
38 |
CUL1 |
8454 |
Affinity Capture-MS |
 |
Homo sapiens |
|
39 |
TFCP2 |
7024 |
Affinity Capture-MS |
 |
Homo sapiens |
|
40 |
SETD1A |
9739 |
Affinity Capture-MS |
 |
Homo sapiens |
|
41 |
PARP2 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
42 |
SOD1 |
6647 |
Affinity Capture-MS |
 |
Homo sapiens |
|
43 |
KIF14 |
9928 |
Affinity Capture-MS |
 |
Homo sapiens |
|
44 |
GAR1 |
54433 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
45 |
ZCRB1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
46 |
MAPK1 |
5594 |
Co-localization |
 |
Homo sapiens |
|
47 |
H2AFZ |
3015 |
Affinity Capture-MS |
 |
Homo sapiens |
|
48 |
TRIM41 |
90933 |
Affinity Capture-MS |
 |
Homo sapiens |
|
49 |
EIF2AK2 |
5610 |
Biochemical Activity |
 |
Homo sapiens |
|
50 |
DLD |
1738 |
Affinity Capture-MS |
 |
Homo sapiens |
|
51 |
MAPK3 |
5595 |
Affinity Capture-MS |
 |
Homo sapiens |
Co-localization |
 |
Homo sapiens |
|
52 |
COX15 |
1355 |
Affinity Capture-MS |
 |
Homo sapiens |
|
53 |
DDX21 |
9188 |
Affinity Capture-MS |
 |
Homo sapiens |
|
54 |
PSMD4 |
5710 |
Reconstituted Complex |
 |
Homo sapiens |
|
55 |
CUL4B |
8450 |
Affinity Capture-MS |
 |
Homo sapiens |
|
56 |
RBM19 |
9904 |
Affinity Capture-MS |
 |
Homo sapiens |
|
57 |
PHF14 |
9678 |
Affinity Capture-MS |
 |
Homo sapiens |
|
58 |
ERCC6 |
|
Affinity Capture-Western |
 |
Homo sapiens |
Affinity Capture-Western |
 |
Homo sapiens |
Far Western |
 |
Homo sapiens |
|
59 |
MCM4 |
4173 |
Affinity Capture-MS |
 |
Homo sapiens |
|
60 |
HIST1H3E |
8353 |
Affinity Capture-MS |
 |
Homo sapiens |
|
61 |
CFDP1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
62 |
ANKHD1 |
54882 |
Affinity Capture-MS |
 |
Homo sapiens |
|
63 |
YAP1 |
10413 |
Affinity Capture-MS |
 |
Homo sapiens |
|
64 |
BARD1 |
580 |
Co-crystal Structure |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
|
65 |
RNF168 |
|
Biochemical Activity |
 |
Homo sapiens |
Biochemical Activity |
 |
Homo sapiens |
|
66 |
SLX4 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
67 |
HIST1H1E |
3008 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
68 |
HIST1H1C |
3006 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
69 |
RPL27A |
6157 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
70 |
HIST1H2BK |
85236 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
71 |
PELP1 |
27043 |
Affinity Capture-MS |
 |
Homo sapiens |
|
72 |
H2AFY |
9555 |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
73 |
PPM1G |
5496 |
Affinity Capture-MS |
 |
Homo sapiens |
Proximity Label-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
Affinity Capture-MS |
 |
Homo sapiens |
|
74 |
DNM1L |
10059 |
Affinity Capture-MS |
 |
Homo sapiens |
|
75 |
HIST1H2BH |
8345 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
76 |
IPO9 |
55705 |
Affinity Capture-MS |
 |
Homo sapiens |
|
77 |
MAP4K1 |
|
Biochemical Activity |
 |
Homo sapiens |
|
78 |
TRIP13 |
9319 |
Co-fractionation |
 |
Homo sapiens |
|
79 |
RING1 |
6015 |
Co-crystal Structure |
 |
Homo sapiens |
|
80 |
TONSL |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
81 |
MIER3 |
166968 |
Affinity Capture-MS |
 |
Homo sapiens |
|
82 |
SF3B2 |
10992 |
Affinity Capture-MS |
 |
Homo sapiens |
|
83 |
MIER1 |
|
Affinity Capture-MS |
 |
Homo sapiens |
|
84 |
HIST1H3A |
8350 |
Affinity Capture-Western |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
85 |
KMT2A |
|
Reconstituted Complex |
 |
Homo sapiens |
|
86 |
HIST2H3C |
126961 |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
Cross-Linking-MS (XL-MS) |
 |
Homo sapiens |
|
87 |
SDHA |
6389 |
Affinity Capture-MS |
 |
Homo sapiens |
|
88 |
BKRF4 |
|
Affinity Capture-MS |
 |
|
Reconstituted Complex |
 |
|
|
89 |
RLIM |
51132 |
Affinity Capture-MS |
 |
Homo sapiens |
|
90 |
USP16 |
|
Biochemical Activity |
 |
Homo sapiens |
|
91 |
UBR7 |
|
Affinity Capture-Western |
 |
Homo sapiens |
|
92 |
HSD17B10 |
3028 |
Affinity Capture-MS |
 |
Homo sapiens |
|
93 |
HNRNPA1 |
3178 |
Affinity Capture-MS |
 |
Homo sapiens |
Co-fractionation |
 |
Homo sapiens |
|
94 |
NAP1L1 |
4673 |
| | | |